Skip to main content Accessibility help
×
Home
  • Print publication year: 2008
  • Online publication date: August 2010

40 - IVF in the Medically Complicated Patient

from PART III - ASSISTED REPRODUCTION

Summary

This chapter discusses the outcome of in vitro fertilization (IVF) in medically complicated patients. A confounding factor for IVF pregnancies is the increased number of multiple pregnancies and the relatively increased number of high-risk pregnancies among women with chronic medical problems. Cancer patients present particular challenges to the IVF unit. Standard IVF protocols are used for controlled ovarian hyperstimulation in human immunodeficiency virus (HIV) discordant couples. The main concerns about IVF and malignant disease relate to the issue of the potential delay in the starting of the patient's chemotherapy or of any possible effect of hormonal changes on the cancer. Obesity might affect the outcome of IVF and pregnancy, but with careful management, a good outcome can be achieved. It has been suggested that systemic lupus erythematosus (SLE) may reduce the success of IVF-ET. The presence of antinuclear antibodies may reduce the implantation rate in IVF patients.
REFERENCES
Steegers, EAP and Wildschut, HIJ. Preparing for pregnancy: preconception care. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 12, pp. 181–203.
Anderson, RA. The patient with malignant disease. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 3, pp. 41–50.
Rueffer, U, Breuer, K, Josting, A, et al. Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 2001; 12:1307–1311.
Pal, L, Leykin, L, Schifren, JL, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod 1998; 13:1837–1840.
Andersen, RA, Kinniburgh, D, Baird, DT. Preliminary evidence of the use of gonadotrophin releasing-hormone antagonist in superovulation/IVF prior to cancer treatment. Hum Reprod 1999; 14:2665–2668.
Oktay, K, Buyuk, E, Davis, O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18:90–95.
Sonmezer, M, Oktay, K. Fertility preservation in female patients. Hum Reprod Update 2004; 10:251–266.
Ethics Committee of the ASRM. HIV and infertility treatment. Fertil Steril 2002; 77: 218–222.
American College of Obstetrics and Gynecologists. HIV: Ethical Guidelines for Obstetricians and Gynecologists, April 2001. ACOG Committee Opinion 255, Washington DC; ACOG, 2001.
The ESHRE Ethics and Law Task Force. Task Force 8: Ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod 2004; 19: 2454–6.
Sauer, MV. The couple discordant for human immunodeficiency virus. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide to Management. Taylor and Francis, London: 2005, Chapter 5, pp. 61–71.
Rizk, B, Dill, R. Counseling HIV patients pursuing infertility investigation and treatment. Hum Reprod 1997;12(3):415–416.
Sauer, MV. Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review. Reprod Biomed Online 2005; 10:135–140.
Semprini, AE, Levi-Seti, P, Bozzo, M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340:1317–1319.
Ola, B, Ledger, L. The obese patient. In: Macklon, NS (ed.), IVF in the Medically Complicated Patient: A Guide To Management. Taylor and Francis, London: 2005, Chapter 7, pp. 87–100.
Wang, JX, Davies, M, Norman, RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000; 321:1320–1321.
Wass, P, Waldenstrom, U, Rossner, S, Hellberg, D. An android body fat distribution in females impairs the pregnancy rate of in- vitro fertilization-embryo transfer. Hum Reprod 1997; 12:2057–2060.
Blumenfeld, Z. The patient with systemic lupus erythematosus. In: Macklon, Nick S (ed.), IVF in the Medically Complicated Patient: A Guide To Management. Taylor and Francis, London: 2005, Chapter 4, pp. 51–60.
Blumenfeld, Z, Shapiro, D, Shteinberg, M, et al. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic erythematosus treated by chemotherapy. Lupus 2000; 9:1–5.
Blumenfeld, Z. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocere. Hum Reprod 2004; 19:1924–1925.
Guballa, N, Sammaritano, L, Schwartzman, S, et al. Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2000; 43:550–556.
Rizk, B, Abdalla, H. In vitro fertilization. In Rizk, B, Abdalla, H (Eds.) Infertility and assisted reproductive technology. Oxford: United Kingdom, Health Press, 2008, Chapter 7, pp. 112–114.